The only other combination selected from secondary screening, rapamycin and IACS-010759, was not validated in our study, however, studies have found that IACS-010759 inhibits cell growth by inducing mammalian Target of Rapamycin (mTOR) suppression in sensitive AML cells (26). The gene discussed is MTOR; the disease is acute myeloid leukemia.